David P. Bonita

David P. Bonita (board member) discloses dealings in 7 companies, chiefly Repare Therapeutics Inc., Acutus Medical, Inc. and ImageneBio, Inc. Between 10 June 2021 and 21 April 2026, the trades on record add up to 24 filings.

In open-market terms, that means 7 purchases worth €32.4M on one side and 7 sales worth €2.0M on the other. The amount is not disclosed for 1 filing. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 7 share grants and 1 option exercise. Since January 2026: 2 purchases and no sales on the market.

The median purchase comes to €5.5M. 5 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Ninety days after publication, 3 purchases show a median change of -16.4%, with the price up in 0% of them. These figures describe past trades and do not predict future prices.

On 23 April 2026 came the latest disclosure, an open-market purchase for €6.4M in Prelude Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.